Product Information
ERYTHROMYCIN 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.7409 per EA under NDC 00093557156. Its NADAC has been published 257 times since Jul 28, 2021.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093557156
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA214549On Market Since
5/4/2021
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 250 MG TABLET has been published 257 times since Jul 28, 2021, and over the history we have for it it has declined 74.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7409 per EA |
|---|---|
| All-time high | $8.8424 (Aug 10, 2022) |
| All-time low | $1.3349 (May 22, 2024) |
| 52-week high | $1.8691 |
| 52-week low | $1.3571 |
| Median price | $3.8997 |
| Average price | $4.0073 |
| Largest weekly change | -54.7% (Apr 17, 2024) |
| Weeks tracked | 257 |
| Tracking since | Jul 28, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.7409 per EA (NDC 00093557156), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 250 MG TABLET has declined 74.5%. It has been tracked across 257 weekly CMS publications since Jul 28, 2021.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 250 MG TABLET?
Since Jul 28, 2021, the NADAC for ERYTHROMYCIN 250 MG TABLET has ranged from a low of $1.3349 (May 22, 2024) to a high of $8.8424 (Aug 10, 2022), with a median of $3.8997 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 250 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ERYTHROMYCIN 250 MG TABLET, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 250 MG TABLET?
ERYTHROMYCIN 250 MG TABLET (NDC 00093557156) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification